These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29328556)

  • 41. Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: when is preoperative coronary angiography necessary?
    Thalji NM; Suri RM; Daly RC; Dearani JA; Burkhart HM; Park SJ; Greason KL; Joyce LD; Stulak JM; Huebner M; Li Z; Frye RL; Schaff HV
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1055-1063, 1064.e1; discussion 1063-1064. PubMed ID: 24012061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Poor Survival After Retransplantation in NASH Cirrhosis.
    Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
    Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between airflow obstruction and coronary atherosclerosis in asymptomatic individuals: evaluation by coronary CT angiography.
    Kim JJ; Kim DB; Jang SW; Cho EJ; Chang K; Baek SH; Youn HJ; Chung WS; Seung KB; Rho TH; Jung JI; Hwang BH
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):641-648. PubMed ID: 29139033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates.
    Rachwan RJ; Kutkut I; Timsina LR; Bou Chaaya RG; El-Am EA; Sabra M; Mshelbwala FS; Rahal MA; Lacerda MA; Kubal CA; Fridell JA; Ghabril MS; Bourdillon PD; Mangus RS
    J Hepatol; 2021 Jul; 75(1):142-149. PubMed ID: 33476745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. External validation and extension of a diagnostic model for obstructive coronary artery disease: a cross-sectional predictive evaluation in 4888 patients of the Austrian Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort.
    Edlinger M; Wanitschek M; Dörler J; Ulmer H; Alber HF; Steyerberg EW
    BMJ Open; 2017 Apr; 7(4):e014467. PubMed ID: 28389492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium.
    Kwong AJ; Devuni D; Wang C; Boike J; Jo J; VanWagner L; Serper M; Jones L; Sharma R; Verna EC; Shor J; German MN; Hristov A; Lee A; Spengler E; Koteish AA; Sehmbey G; Seetharam A; John N; Patel Y; Kappus MR; Couri T; Paul S; Salgia RJ; Nhu Q; Frenette CT; Lai JC; Goel A;
    Liver Transpl; 2020 Nov; 26(11):1492-1503. PubMed ID: 33047893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation of coronary artery plaque location to extent of coronary artery disease studied by computed tomographic angiography.
    Grunfeld C; Scherzer R; Varosy PD; Ambarish G; Nasir K; Budoff M
    J Cardiovasc Comput Tomogr; 2010; 4(1):19-26. PubMed ID: 20159623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coronary artery disease as a risk factor for metabolic dysfunction-associated steatotic liver disease and liver fibrosis.
    Vega L; Simian D; Gajardo AI; Salinas M; Urra A; Cattaneo M; Pino R; Roblero JP; Urzúa Á; Rojas K; Poniachik J
    Ann Hepatol; 2024; 29(4):101511. PubMed ID: 38710474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Obesity, metabolic syndrome and cardiovascular prognosis: from the Partners coronary computed tomography angiography registry.
    Hulten EA; Bittencourt MS; Preston R; Singh A; Romagnolli C; Ghoshhajra B; Shah R; Abbasi S; Abbara S; Nasir K; Blaha M; Hoffmann U; Di Carli MF; Blankstein R
    Cardiovasc Diabetol; 2017 Jan; 16(1):14. PubMed ID: 28122619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
    Eshraghian A; Nikeghbalian S; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
    HPB (Oxford); 2020 Apr; 22(4):521-528. PubMed ID: 31431413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of Recurrent NASH-Related Allograft Cirrhosis.
    Kakar S; Dugum M; Cabello R; Humar A; Ahmad J; Malik SM
    Dig Dis Sci; 2019 May; 64(5):1356-1363. PubMed ID: 30560336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
    Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
    Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of significant coronary artery disease by noninvasive anatomical and functional imaging.
    Neglia D; Rovai D; Caselli C; Pietila M; Teresinska A; Aguadé-Bruix S; Pizzi MN; Todiere G; Gimelli A; Schroeder S; Drosch T; Poddighe R; Casolo G; Anagnostopoulos C; Pugliese F; Rouzet F; Le Guludec D; Cappelli F; Valente S; Gensini GF; Zawaideh C; Capitanio S; Sambuceti G; Marsico F; Perrone Filardi P; Fernández-Golfín C; Rincón LM; Graner FP; de Graaf MA; Fiechter M; Stehli J; Gaemperli O; Reyes E; Nkomo S; Mäki M; Lorenzoni V; Turchetti G; Carpeggiani C; Marinelli M; Puzzuoli S; Mangione M; Marcheschi P; Mariani F; Giannessi D; Nekolla S; Lombardi M; Sicari R; Scholte AJ; Zamorano JL; Kaufmann PA; Underwood SR; Knuuti J;
    Circ Cardiovasc Imaging; 2015 Mar; 8(3):. PubMed ID: 25711274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibromyalgia symptoms and cirrhosis.
    Rogal SS; Bielefeldt K; Wasan AD; Szigethy E; Lotrich F; DiMartini AF
    Dig Dis Sci; 2015 May; 60(5):1482-9. PubMed ID: 25433921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Favorable clinical outcome of nonalcoholic liver cirrhosis patients with coronary artery disease: A population-based study.
    Tsai MC; Yang TW; Wang CC; Wang YT; Sung WW; Tseng MH; Lin CC
    World J Gastroenterol; 2018 Aug; 24(31):3547-3555. PubMed ID: 30131661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C.
    Henson JB; Wilder JM; Kappus MR; Barbas AS; Moylan CA; Niedzwiecki D; Muir AJ; Berg CL; Patel YA
    Transplantation; 2020 Jun; 104(6):e164-e173. PubMed ID: 32150036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
    Afzali A; Berry K; Ioannou GN
    Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease.
    Daffara V; Verdoia M; Rolla R; Nardin M; Marino P; Bellomo G; Carriero A; De Luca G;
    Nutr Metab Cardiovasc Dis; 2017 Sep; 27(9):775-783. PubMed ID: 28779988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
    Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
    Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of Occult Hepatitis C Virus Infection in Liver Transplant Patients With Cryptogenic Cirrhosis.
    Yaghobi R; Kazemi MJ; Geramizadeh B; Malek Hosseini SA; Moayedi J
    Exp Clin Transplant; 2020 Apr; 18(2):206-209. PubMed ID: 30346262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.